Original Article

You have free access to this content

Pretherapeutic identification of high-risk acute myeloid leukemia (AML) patients from immunophenotypic, cytogenetic, and clinical parameters

  1. G. Valet1,*,
  2. R. Repp2,
  3. H. Link3,
  4. A. Ehninger4,
  5. M. Gramatzki M2

Article first published online: 21 APR 2003

DOI: 10.1002/cyto.b.10028

Issue

Cytometry Part B: Clinical Cytometry

Cytometry Part B: Clinical Cytometry

Special Issue: Cytomics in Predictive Medicine

Volume 53B, Issue 1, pages 4–10, May 2003

Additional Information

How to Cite

Valet, G., Repp, R., Link, H., Ehninger, A. and Gramatzki M, M. (2003), Pretherapeutic identification of high-risk acute myeloid leukemia (AML) patients from immunophenotypic, cytogenetic, and clinical parameters. Cytometry, 53B: 4–10. doi: 10.1002/cyto.b.10028

Author Information

  1. 1

    Max-Planck-Institut für Biochemie, Martinsried, Germany

  2. 2

    Med.Klinik III der Universität Erlangen, Germany

  3. 3

    Klinikum Kaiserslautern, Germany

  4. 4

    Med.Klinik und Poliklinik I der Universität Dresden, Dresden, Germany

*Max-Planck-Institut für Biochemie, Arbeitsgruppe Zellbiochemie, Am Klopferspitz 18a, D-82152 Martinsried, Germany

Publication History

  1. Issue published online: 21 APR 2003
  2. Article first published online: 21 APR 2003
  3. Manuscript Accepted: 17 FEB 2003
  4. Manuscript Received: 15 JAN 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (80K)

LITERATURE CITED

  • 1
    Löwenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med 1999; 341: 1051–1062.
  • 2
    Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, Pettenati MJ, Patil SR, Rao KW, Watson MS, Koduru PRK, Moore JO, Stone RM, Mayer RJ, Feldman EJ, Davey FR, Schiffer CA, Larson RA, Bloomfield CD. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from cancer and leukemia group B (CALGB 8461). Blood 2002; 100: 4325–4336.
  • 3
    Frohling S, Schlenk RF, Breitruck J, Benner A, Kreitmeier S, Tobis K, Dohner H, Dohner K. Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: A study of the AML study group Ulm. Blood 2002; 100: 4372–4380.
  • 4
    Bernstein ID. CD33 as a target for selective ablation of acute myeloid leukemia. Clin Lymphoma 2002; 2 (Suppl 1): 9–11.
  • 5
    Di Bona E, Sartori R, Zambello R, Guercini N, Madeo D, Rodeghiero F. Prognostic significance of CD56 antigen expression in acute myeloid leukemia. Haematologica 2002; 87: 250–256.
  • 6
    Raspadori D, Damiani D, Michieli M, Stocchi R, Gentili S, Gozzetti A, Masolini P, Michelutti A, Geromin A, Fanin R, Lauria F. CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome. Haematologica 2002; 87: 1135–1140.
  • 7
    Valet G. Predictive medicine by cytomics: potential and challenges. J Biol Regul Homeost Agents 2002; 16: 164–167.
  • 8
    Repp R, Schaekel U, Helm G, Thiede C, Soucek S, Pascheberg U, Wandt H, Aulitzky W, Bodenstein H, Kuse R, Link H, Ehninger G, Gramatzki M, AML-SHG study group. Immunophenotyping is an independent factor for risk stratification in AML. Cytometry Part B 2003; 53B: 11–19.
    Direct Link:
  • 9
    Bartsch R, Arland M, Lange S, Kahl C, Valet G, Höffkes H-G. Lymphoma discrimination by computerized triple matrix analysis of list mode data from three-color flow cytometric immunophenotypes of bone marrow aspirates. Cytometry 2000; 41: 9–18.
    Direct Link:
  • 10
    Valet G, Kahle H, Otto F, Bräutigam E, Kestens L. Prediction and precise diagnosis of diseases by data pattern analysis in multiparameter flow cytometry: melanoma, juvenile asthma and human immunodeficiency virus infection. In: DarzynkiewiczZ, CrissmannHA, RobinsonJP, editors. Cytometry. 3rd edition. San Diego: Academic Press; 2001; Valet G, Kahle H, Otto F, Bräutigam E, Kestens L. Meth Cell Biol 64: 487–508.
  • 11
    Tarnok A, Bocsi J, Pipek M, Osmancik P, Valet G, Schneider P, Hambsch J. Preoperative prediction of postoperative edema and effusion in pediatric cardiac surgery by altered antigen expression patterns on granulocytes and monocytes. Cytometry (CCC) 2001; 46: 247–253.
    Direct Link:
  • 12
    Stone RM. The difficult problem of acute myeloid leukemia in the older adult. CA-A Cancer J Clinicians 2002; 52: 363–371.
    Direct Link:
  • 13
    Kern W, Schoch C, Haferlach T, Braess J, Unterhalt M, Wörmann B, Büchner T, Hiddemann W. Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy: relevance of cytogenetic abnormalities. Leukemia 2000; 14: 226–231.
View Full Article (HTML) Get PDF (80K)